Living Cell Technologies Limited - Company & Market Research Reports

Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore function in New Zealand. Its lead product is NTCELL, an alginate coated capsule, which is in Phase IIb clinical trial for the treatment of Parkinson's disease. In addition to this, NTCELL has the potential to be used in a number of other central nervous system indications, including Huntington's and Alzheimer's. The company was founded in 1987 and is based in Auckland, New Zealand.

From
From
Parkinson's Disease - Pipeline Review, H1 2018 - Product Thumbnail Image

Parkinson's Disease - Pipeline Review, H1 2018

  • Drug Pipelines
  • 881 Pages
From
Huntington Disease - Pipeline Review, H2 2017 - Product Thumbnail Image

Huntington Disease - Pipeline Review, H2 2017

  • Drug Pipelines
  • 287 Pages
From
Huntington Disease - Pipeline Review, H1 2017 - Product Thumbnail Image

Huntington Disease - Pipeline Review, H1 2017

  • Drug Pipelines
  • 299 Pages
From
From
From
From
From
From
Alzheimer's Disease - Pipeline Review, H2 2018 - Product Thumbnail Image

Alzheimer's Disease - Pipeline Review, H2 2018

  • Drug Pipelines
  • 1333 Pages
From
From
From
From
Stroke - Pipeline Review, H2 2018 - Product Thumbnail Image

Stroke - Pipeline Review, H2 2018

  • Drug Pipelines
  • 544 Pages
From
Wounds - Pipeline Review, H2 2017 - Product Thumbnail Image

Wounds - Pipeline Review, H2 2017

  • Drug Pipelines
  • 209 Pages
From
Wounds - Pipeline Review, H1 2017 - Product Thumbnail Image

Wounds - Pipeline Review, H1 2017

  • Drug Pipelines
  • 186 Pages
From
From
Loading Indicator
adroll